Bergstein Ivan 4
4 · STEMLINE THERAPEUTICS INC · Filed Aug 16, 2019
Insider Transaction Report
Form 4
Bergstein Ivan
DirectorCEO, Pres., Treas., Sec.10% Owner
Transactions
- Sale
Common Stock
2019-08-14$14.73/sh−35,010$515,697→ 2,570,801 total
Footnotes (3)
- [F1]In connection with the vesting of 62,500 shares on August 13, 2019, a total of 35,010 shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
- [F2]Reflects the weighted average sale price. The range of prices for such transaction is $14.50 to $15.44. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Of the 2,570,801 shares, 687,200 shares are restricted stock.